Claritev Responds to DOJ Criminal Antitrust Probe Allegations, Confirms Ongoing Investigation Since 2024
CTEV is trading near its 52-week low of $11.5 (1.8% above the low).
Summary
Claritev Corp filed an 8-K to address a news article alleging a criminal antitrust probe by the DOJ, confirming an ongoing investigation since August 2024 but stating it has not been informed it is a target.
Key Events · Legal and Risk Events · CTEV
-
DOJ Antitrust Probe Allegation
Claritev is responding to a May 14, 2026 article alleging a criminal antitrust probe by the Department of Justice.
-
Ongoing Investigation Confirmed
The company confirms it received a confidential grand jury subpoena from the DOJ in August 2024 regarding a health insurance investigation.
-
Not a Target (Company's Stance)
Claritev states the DOJ has not informed them that they are a target of the investigation in the two years since the subpoena.
-
Full Cooperation
The company asserts it has been fully cooperating with the DOJ.
Analysis · CTEV · Trade & Services
This filing addresses a serious legal and regulatory risk for Claritev Corp. While the company clarifies that the investigation has been ongoing since August 2024 and they have not been designated as a target, the public allegation of a "criminal antitrust probe" introduces significant uncertainty and potential for substantial legal costs and reputational damage. This comes at a challenging time, with the company reporting increased net losses and its stock trading near 52-week lows. Investors will be closely watching for any further updates on the DOJ investigation.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 37.4% of the 3413 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CTEV was trading at $11.71 on NYSE in the Trade & Services sector, with a market capitalization of approximately $199.6M. The 52-week trading range was $11.50 to $74.07. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.